Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03948776 · ClinicalTrials.gov registry record

Body Composition Ultrasound for Patients With Heart Failure

A clinical trial of Heart Failure, sponsored by Tufts Medical Center.

Completed
Registry status
48
Enrollment target
1
Study location

NCT03948776: Completed study of Heart Failure, sponsored by Tufts Medical Center.

NCT03948776 is a study of Heart Failure that has completed, run by Tufts Medical Center. The registered enrollment target is 48 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03948776, a study of Heart Failure, has completed, sponsored by Tufts Medical Center.

COMPLETED
Registry status
48 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine whether skeletal muscle ultrasound is a useful technique for measuring low muscle mass in patients with heart failure (HF). Muscle wasting and abnormal muscle quality has been identified in patients with advanced HF and may contribute to patients' physical limitations. However assessments of body composition for patients with HF currently rely on the research tool of dual X-ray absorptiometry (DXA) for measurements of skeletal muscle mass, which is limited by cost, use of radiation, and the need for patients to be transported to the DXA scanner for imaging. Therefore this observational study is designed to validate a new approach that allows a safe and portable assessment of body composition.

Primary Outcome

This is the fat free mass calculated by whole-body DXA, which is the gold standard for measuring skeletal muscle mass

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST BodyMetrix body composition ultrasound
  • DIAGNOSTIC_TEST BodyMetrix body composition ultrasound only

Study Locations (1)

Massachusetts

  • Tufts Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2019-05-24
Est. Completion 2023-12-31
Tufts Medical Center

169 total trials

What the finished NCT03948776 record still lists

NCT03948776 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which BodyMetrix body composition ultrasound is the first listed.

NCT03948776 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03948776 about?

NCT03948776 is a clinical study titled "Body Composition Ultrasound for Patients With Heart Failure". This study aims to determine whether skeletal muscle ultrasound is a useful technique for measuring low muscle mass in patients with heart failure (HF). Muscle wasting and abnormal muscle quality has been identified in patients with advanced HF and may contribute to patients' physical limitations. H...

What is the current status of trial NCT03948776?

This trial is currently completed. The enrollment target is 48 participants. The study started on 2019-05-24. Estimated completion is 2023-12-31.

What conditions does trial NCT03948776 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT03948776?

The interventions under investigation include: BodyMetrix body composition ultrasound (DIAGNOSTIC_TEST), BodyMetrix body composition ultrasound only (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03948776?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03948776 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03948776's enrollment target sits among peer trials

48 294th of 397 higher than 104 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03948776, the US trial registry maintained by the National Library of Medicine. NCT03948776 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.